Are Rising Productivity and Unit Labor Costs Helping the Rate Hike Case?
A report on Wednesday from the U.S. Bureau of Labor Statistics (BLS) showed both productivity and unit labor costs were higher in the third quarter.
A report on Wednesday from the U.S. Bureau of Labor Statistics (BLS) showed both productivity and unit labor costs were higher in the third quarter.
The holiday season is known for lavish food, gifts and time spent with friends and family. Of course this does come at a price.
It is that time of year when investors and consumers alike are starting to think about the end of this year and the start of next one.
U.S. sales of distressed homes totaled more than 9% of all homes sold in September of this year, according to data posted Wednesday by CoreLogic.
New competition for gamblers is likely to compress revenues for the Atlantic City casinos, according to Moody's Investor Services.
U.S. commercial crude inventories increased by 1.2 million barrels last week, according to the U.S. Energy Information Administration.
Dollar General is scheduled to report its fiscal third-quarter financial results before the markets open on Thursday.
Investors have been using the ADP Payrolls report the TrimTabs employment growth report as a preliminary tool to judge and predict what the Labor Department report will say.
Investors have been using the ADP Payrolls report, released 48 hours ahead of the Labor Department report, as a preliminary tool to judge and predict what the payrolls report will be.
Yingli Green Energy posted third-quarter fiscal 2015 results before markets opened on Wednesday morning.
A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical issues muddy the waters.
Until late October, Under Armour was handily outperforming Nike. That changed when Under Armour's very high valuation and expectations finally got ahead of themselves and investors dumped the stock.
InVivo Therapeutics announced a new strategy for the treatment of chronic spinal cord injury.
With the holiday shopping season in full-swing, you can bet the video game companies with the hot titles stand to have a huge fourth quarter.
It looks like Wednesday will be a huge day for Zafgen, considering the most recent development in the beloranib study.